MONTECUCCO, FABRIZIO
 Distribuzione geografica
Continente #
EU - Europa 43.282
Totale 43.282
Nazione #
IT - Italia 43.282
Totale 43.282
Città #
Genova 36.362
Rapallo 3.738
Genoa 3.070
Bordighera 112
Totale 43.282
Nome #
Stairs instead of elevators at the workplace decreases PCSK9 levels in a healthy population 210
Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin. 176
C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytes. 165
Autophagy in blood cancers: biological role and therapeutic implications. 165
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways. 165
Update on cardiotoxicity of anti-cancer treatments 165
Early reduction of matrix metalloproteinase-8 serum levels is associated with leptin drop and predicts diabetes remission after bariatric surgery 165
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 164
The vulnerable coronary plaque: update on imaging technologies. 163
Alamandine abrogates neutrophil degranulation in atherosclerotic mice 161
CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice. 159
Reply to "Management of left ventricular thrombosis in patients with apical aneurysm". 157
Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability. 156
Update on the role of cannabinoid receptors after ischemic stroke. 155
Immune complexes induce monocyte survival through defined intracellular pathways 153
C-Reactive Protein Levels at the Midpregnancy Can Predict Gestational Complications 153
Nephrotic syndrome in a patient with IgM myeloma with associated neutrophilia. 151
Reactive oxygen-induced cardiac intracellular pathways during ischemia and reperfusion. 151
Pathophysiology and treatments of oxidative injury in ischemic stroke: Focus on the phagocytic NADPH Oxidase 2 150
CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke. 149
Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology. 149
An Oral Formulation of Angiotensin-(1-7) Reverses Corpus Cavernosum Damages Induced by Hypercholesterolemia. 149
Atherosclerosis is an inflammatory disease. 148
Pathophysiological role of neutrophils in acute myocardial infarction. 148
Mutation Analysis of PRKAR1A Gene in a Patient with Atrial Myxoma 148
Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis 148
Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis. 147
Insulin primes human neutrophils for CCL3-induced migration: crucial role for JNK 1/2. 146
A9.11 Anti-apolipoprotein A1 autoantibodies induce tissue factor activity and expression: a role in atherothrombosis. 146
CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways. 144
Effect of blockage of the endocannabinoid system by CB(1) antagonism on cardiovascular risk. 143
Statins and stent thrombosis. 143
Anemia Due to Inflammation in an Anti-Coagulated Patient with Blue Rubber Bleb Nevus Syndrome 143
Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways. 142
High baseline C-reactive protein levels predict partial type 2 diabetes mellitus remission after biliopancreatic diversion 142
The role of adipocytokines in atherogenesis and atheroprogression. 142
Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity. 142
Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents 142
Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery. 141
Angiotensin II receptor antagonists in acute coronary syndromes. 141
Treatment with CB 2 Agonist JWH-133 Reduces Histological Features Associated with Erectile Dysfunction in Hypercholesterolemic Mice. 141
Treatment with apixaban in a patient with recent chronic subdural haematoma: a case report. 141
Dexamethasone-induced apoptosis of human monocytes exposed to immune complexes. Intervention of CD95-and XIAP-dependent pathways. 140
Update on the Pathophysiological Activities of the Cardiac Molecule Cardiotrophin-1 in Obesity. 140
Alpha-fetoprotein: A controversial prognostic biomarker for small hepatocellular carcinoma. 139
Potential pathophysiological role for the vitamin D deficiency in essential hypertension. 139
CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion. 138
5-fluorouracil causes endothelial cell senescence: Potential protective role of glucagon-like peptide 1 138
Levels of serum uric acid at admission for hypoglycaemia predict 1-year mortality 137
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques. 137
Role of matrix metalloproteinases in animal models of ischemic stroke. 137
Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors As Therapeutics: Rationales, Controversies, Clinical Experience. 137
Induction of neutrophil chemotaxis by leptin - Crucial role for p38 and Src kinases. 137
Cannabinoid receptors in acute and chronic complications of atherosclerosis. 136
An emerging role of glucagon-like Peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes. 136
Apelin-13 treatment enhances the stability of atherosclerotic plaques 136
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice. 136
Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice. 135
Myostatin mediates abdominal aortic atherosclerosis progression by inducing vascular smooth muscle cell dysfunction and monocyte recruitment 134
Human mesenchymal stem cells inhibit neutrophil apoptosis: A model for neutrophil preservation in the bone marrow niche. 134
Impact of Systemic Inflammation and Autoimmune Diseases on apoA-I and HDL Plasma Levels and Functions. 134
Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice 134
Delayed apoptosis of human monocytes exposed to immune complexes is reversed by oxaprozin: role of the Akt/I kappaB kinase/nuclear factor kappaB pathway. 133
Update on the role of Angiotensin in the pathophysiology of coronary atherothrombosis. 133
Insulin resistance: a proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instability? 133
Improving Reconstituted HDL Composition for Efficient Post-Ischemic Reduction of Ischemia Reperfusion Injury. 133
Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4 133
Coronary stenting: A matter of revascularization 132
Update on statin-mediated anti-inflammatory activities in atherosclerosis. 132
Does non-alcoholic fatty liver disease (NAFLD) increase cardiovascular risk? 131
Update on the Pathophysiological Role of Intracellular Signaling Pathways in Atherosclerotic Plaques and Ischemic Myocardium. 131
Anti-apolipoprotein a-1 IgG levels predict coronary artery calcification in obese but otherwise healthy individuals. 131
Update on the treatments of non-alcoholic fatty liver disease (NAFLD). 131
Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke 131
Statins in the treatment of acute ischemic stroke. 131
Inflammation in the pathophysiology of essential hypertension. 130
The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury. 130
Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis 130
Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability 129
Elevated E-selectin and diastolic blood pressure in diabetic children. 129
Glucagon-Like Peptide-1 Secreting Cell Function as well as Production of Inflammatory Reactive Oxygen Species Is Differently Regulated by Glycated Serum and High Levels of Glucose. 129
Sepsis by Pasteurella multocida in an Elderly Immunocompetent Patient after a Cat Bite 129
Data regarding the effects of thrombin and dabigatran-inhibited thrombin on protease-activated receptor 1 and activation of human atrial fibroblasts 129
Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response 129
The immune response is involved in atherosclerotic plaque calcification: could the RANKL/RANK/OPG system be a marker of plaque instability? 129
Serum Resistin and Inflammatory and Endothelial Activation Markers in Obese Adolescents. 129
Evidence on the protective role of high-density lipoprotein (HDL) in HIV-infected individuals. 128
The Role of the Intraplaque Vitamin D System in Atherogenesis. 128
Sofosbuvir/velpatasvir: A promising combination 128
New evidence for nicotinic acid treatment to reduce atherosclerosis. 128
Thrombin induces protease-activated receptor 1 signaling and activation of human atrial fibroblasts and dabigatran prevents these effects 128
HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial. 128
Statins, ACE inhibitors and ARBs in cardiovascular disease. 128
Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases. 128
Prognostic value of PCSK9 levels in patients with acute coronary syndromes 128
Toll-like receptor 7 protects from atherosclerosis by constraining "inflammatory" macrophage activation. 127
Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury 127
Glucose-targeted therapy for subjects with Type 2 Diabetes Mellitus: "Primum non nocere" 127
Pre-surgery age-adjusted Charlson Comorbidity Index is associated with worse outcomes in acute cholecystitis 127
Pathophysiological role of the renin-angiotensin system on erectile dysfunction. 127
Totale 14.067
Categoria #
all - tutte 124.339
article - articoli 121.054
book - libri 0
conference - conferenze 400
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.885
Totale 248.678


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.112 0 0 0 0 0 0 0 0 0 0 1.058 1.054
2019/202016.573 581 317 437 1.959 1.558 1.978 2.783 1.501 1.613 2.061 1.219 566
2020/20215.621 331 609 443 750 374 321 203 695 348 713 262 572
2021/20225.913 252 459 303 487 347 469 361 1.285 395 537 280 738
2022/20234.692 560 280 56 444 654 825 5 395 853 21 492 107
2023/20242.342 135 334 84 296 285 510 204 215 160 92 27 0
Totale 45.107